LIM
FBT icon

Leavell Investment Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Leavell Investment Management’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,440
Closed -$389K – 386
2016
Q1 		$389K Sell
4,440
-2,145
-33% -$189K 0.06% 265
2015
Q4 		$744K Sell
6,585
-340
-5% -$36.6K 0.11% 178
2015
Q3 		$702K Sell
6,925
-90
-1% -$10.7K 0.11% 181
2015
Q2 		$870K Buy
7,015
+410
+6% +$49.5K 0.14% 178
2015
Q1 		$781K Buy
+6,605
New +$747K 0.12% 191
2014
Q3 		– Sell
-10,100
Closed -$832K – 401
2014
Q2 		$832K Sell
10,100
-1,200
-11% -$91.7K 0.13% 181
2014
Q1 		$867K Buy
11,300
+1,000
+10% +$78K 0.14% 171
2013
Q4 		$713K Buy
10,300
+200
+2% +$13.1K 0.12% 183
2013
Q3 		$654K Buy
10,100
+1,100
+12% +$69.6K 0.12% 180
2013
Q2 		$524K Buy
+9,000
New +$514K 0.1% 202

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
SG
Societe Generale $14.1B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return

Leavell Investment Management's FBT Position: Q2 2016 in Review

Leavell Investment Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2016, closing a stake of 4,440 shares — an estimated $389K sold.

Leavell Investment Management first reported a position in FBT in Q2 2013 and held it in 10 quarters. The position peaked at $870K in Q2 2015. 107 funds tracked by Wall St. Rank hold FBT as of Q2 2016.

  • Leavell Investment Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2016 after selling out during the quarter.
  • Leavell Investment Management sold 4,440 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2016, an estimated $389K.
  • Leavell Investment Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and held it in 10 quarters.
  • Leavell Investment Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $870K in Q2 2015.
  • 107 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2016.

Based on Leavell Investment Management's 13F filing for Q2 2016, filed 18 Jul 2016.